Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

被引:37
|
作者
Boesen, Erika I. [1 ]
Williams, Douglas L. [1 ]
Pollock, Jennifer S. [1 ]
Pollock, David M. [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
hypertension; kidney; macrophage; mineralocorticoid; T-lymphocyte; IMMUNE CELL INFILTRATION; ANGIOTENSIN-II; SENSITIVE HYPERTENSION; BLOOD-PRESSURE; RENAL DAMAGE; MINERALOCORTICOID RECEPTORS; ARTERIAL-PRESSURE; OXIDATIVE STRESS; T-CELL; KIDNEY;
D O I
10.1111/j.1440-1681.2010.05428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18 146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [41] Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/cSRC pathway
    Wenceslau, Camilla F.
    Rossoni, Luciana V.
    JOURNAL OF HYPERTENSION, 2014, 32 (03) : 542 - 554
  • [42] A review of deoxycorticosterone acetate-salt hypertension and its relevance for cardiovascular physiotherapy research
    Lee, Lim-Kyu
    Kim, Mee-Young
    Kim, Ju-Hyun
    Lee, Jeong-Uk
    Park, Byoung-Sun
    Yang, Seung-Min
    Jeon, Hye-Joo
    Lee, Won-Deok
    Noh, Ji-Woong
    Kwak, Taek-Yong
    Lee, Tae-Hyun
    Kim, Ju-Young
    Kim, Hye-Young
    Hwang, Byong-Yong
    Kim, Bokyung
    Kim, Junghwan
    JOURNAL OF PHYSICAL THERAPY SCIENCE, 2015, 27 (01) : 303 - 307
  • [43] Uric Acid Does Not Affect the Acetylcholine-Induced Relaxation of Aorta from Normotensive and Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Szasz, Theodora
    Watts, Stephanie W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (03) : 758 - 763
  • [44] Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension
    Northcott, C
    Florian, JA
    Dorrance, A
    Watts, SW
    HYPERTENSION, 2001, 38 (06) : 1337 - 1341
  • [45] Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats
    Yemane, Henok
    Busauskas, Marius
    Burris, Sarah K.
    Knuepfer, Mark M.
    EXPERIMENTAL PHYSIOLOGY, 2010, 95 (01) : 51 - 55
  • [46] Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt
    Somers, MJ
    Mavromatis, K
    Galis, ZS
    Harrison, DG
    CIRCULATION, 2000, 101 (14) : 1722 - 1728
  • [47] Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress
    Qi-Zhi Chen
    Wei-Qing Han
    Jing Chen
    Ding-Liang Zhu
    Ping-Jin Chen-Yan
    Hypertension Research, 2013, 36 : 306 - 312
  • [48] Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress
    Chen, Qi-Zhi
    Han, Wei-Qing
    Chen, Jing
    Zhu, Ding-Liang
    Chen-Yan
    Gao, Ping-Jin
    HYPERTENSION RESEARCH, 2013, 36 (04) : 306 - 312
  • [49] ANTIOXIDANT TREATMENT RESTORES PREJUNCTIONAL REGULATION OF PURINERGIC TRANSMISSION IN MESENTERIC ARTERIES OF DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE RATS
    Demel, S. L.
    Dong, H.
    Swain, G. M.
    Wang, X.
    Kreulen, D. L.
    Galligan, J. J.
    NEUROSCIENCE, 2010, 168 (02) : 335 - 345
  • [50] Angiotensin Type 1a Receptors in the Subfornical Organ Are Required for Deoxycorticosterone Acetate-Salt Hypertension
    Hilzendeger, Aline M.
    Cassell, Martin D.
    Davis, Deborah R.
    Stauss, Harald M.
    Mark, Allyn L.
    Grobe, Justin L.
    Sigmund, Curt D.
    HYPERTENSION, 2013, 61 (03) : 716 - +